NEURON CULTURES FOR CLN6 BATTEN DISEASE STUDIES

Information

  • Research Project
  • 6529491
  • ApplicationId
    6529491
  • Core Project Number
    R21NS040297
  • Full Project Number
    5R21NS040297-03
  • Serial Number
    40297
  • FOA Number
    PAS-99-080
  • Sub Project Id
  • Project Start Date
    9/8/2000 - 24 years ago
  • Project End Date
    8/31/2003 - 21 years ago
  • Program Officer Name
    OSTER-GRANITE, MARY LOU
  • Budget Start Date
    9/1/2002 - 22 years ago
  • Budget End Date
    8/31/2003 - 21 years ago
  • Fiscal Year
    2002
  • Support Year
    3
  • Suffix
  • Award Notice Date
    8/30/2002 - 22 years ago
Organizations

NEURON CULTURES FOR CLN6 BATTEN DISEASE STUDIES

DESCRIPTION (application abstract): The neuronal ceroid lipofuscinoses (NCLs, Batten disease) are inherited pediatric neurodegenerative diseases. The aim of this application is to exploit neuron cultures developed from an ovine model as an in vitro model of human disease and use it, in combination with whole animal studies, to study the mechanism of neurodegeneration and explore possible therapies. The NCLs are characterized by profound neurodegeneration and the intracellular accumulation of subunit c of mitochondrial ATP synthase. Cortical neuronal cultures have been established from affected sheep and storage body accumulation observed in cultured cells. This investigation will optimize these neuron Cultures as a model of the in situ pathology. The mechanism of neurodegeneration will be studied in them. Specific hypotheses to be tested are that subunit c storage is directly related to neurodegeneration, that a disruption in the endosome-lysosome pathway is central to the neurodegeneration and that accumulation of subunit c results in over-activity of an oligomeric subunit c ionpore in the neuronal plasma membrane. The role of apoptosis and excitotoxicity will be examined and the efficacy of IGF1 and other growth factors that might overcome neurodegeneration tested. Chimeric normal/affected sheep will be generated to delineate the possibilities for gene and enzyme therapy. The clinical course of disease will be monitored in affected sheep transgenically overexpressing IGF1 in brain, to determine if this ameliorates the development of symptoms. Possible therapies will be tested in whole animal experiments. Results will be relevant to understanding the pathobiology of the NCLs and will test the likelihood of benefits of possible treatments. Findings will also be relevant to understanding other protein storing neurodegenerative diseases, such as Alzheimer's disease.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R21
  • Administering IC
    NS
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    125000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
    NINDS:125000\
  • Funding Mechanism
  • Study Section
    NSD
  • Study Section Name
    National Institute of Neurological Disorders and Stroke Initial Review Group
  • Organization Name
    LINCOLN UNIVERSITY
  • Organization Department
  • Organization DUNS
    592214472
  • Organization City
    CANTERBURY
  • Organization State
  • Organization Country
    NEW ZEALAND
  • Organization Zip Code
    8000
  • Organization District
    NEW ZEALAND